These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 37080433)
41. The autotaxin-lysophosphatidic acid pathway in pathogenesis of rheumatoid arthritis. Orosa B; García S; Conde C Eur J Pharmacol; 2015 Oct; 765():228-33. PubMed ID: 26297977 [TBL] [Abstract][Full Text] [Related]
42. Activation of fibroblast-like synoviocytes derived from rheumatoid arthritis via lysophosphatidic acid-lysophosphatidic acid receptor 1 cascade. Miyabe Y; Miyabe C; Iwai Y; Yokoyama W; Sekine C; Sugimoto K; Harigai M; Miyasaka M; Miyasaka N; Nanki T Arthritis Res Ther; 2014 Oct; 16(5):461. PubMed ID: 25273676 [TBL] [Abstract][Full Text] [Related]
43. Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer. Shida D; Watanabe T; Aoki J; Hama K; Kitayama J; Sonoda H; Kishi Y; Yamaguchi H; Sasaki S; Sako A; Konishi T; Arai H; Nagawa H Lab Invest; 2004 Oct; 84(10):1352-62. PubMed ID: 15220934 [TBL] [Abstract][Full Text] [Related]
44. Role of lysophosphatidic acid in ion channel function and disease. Hernández-Araiza I; Morales-Lázaro SL; Canul-Sánchez JA; Islas LD; Rosenbaum T J Neurophysiol; 2018 Sep; 120(3):1198-1211. PubMed ID: 29947596 [TBL] [Abstract][Full Text] [Related]
45. Molecular mechanisms of cyclic phosphatidic acid-induced lymphangiogenic actions in vitro. Okuyama K; Mizuno K; Nittami K; Sakaue H; Sato T Microvasc Res; 2022 Jan; 139():104273. PubMed ID: 34699844 [TBL] [Abstract][Full Text] [Related]
46. Emerging Roles of Lysophosphatidic Acid in Macrophages and Inflammatory Diseases. Jiang S; Yang H; Li M Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569902 [TBL] [Abstract][Full Text] [Related]
47. The autotaxin-lysophosphatidic acid-lysophosphatidic acid receptor cascade: proposal of a novel potential therapeutic target for treating glioblastoma multiforme. Tabuchi S Lipids Health Dis; 2015 Jun; 14():56. PubMed ID: 26084470 [TBL] [Abstract][Full Text] [Related]
48. Lysophosphatidic acid receptors in cancer pathobiology. Tsujiuchi T; Araki M; Hirane M; Dong Y; Fukushima N Histol Histopathol; 2014 Mar; 29(3):313-21. PubMed ID: 24194373 [TBL] [Abstract][Full Text] [Related]
49. Non-Edg family LPA receptors: the cutting edge of LPA research. Yanagida K; Ishii S J Biochem; 2011 Sep; 150(3):223-32. PubMed ID: 21746769 [TBL] [Abstract][Full Text] [Related]
50. Novel implications for lysophospholipids, lysophosphatidic acid and sphingosine 1-phosphate, as drug targets in cancer. Peyruchaud O Anticancer Agents Med Chem; 2009 May; 9(4):381-91. PubMed ID: 19442039 [TBL] [Abstract][Full Text] [Related]
51. Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance. Lin ME; Herr DR; Chun J Prostaglandins Other Lipid Mediat; 2010 Apr; 91(3-4):130-8. PubMed ID: 20331961 [TBL] [Abstract][Full Text] [Related]
52. Lysophosphatidic Acid Signaling in Cancer Cells: What Makes LPA So Special? Balijepalli P; Sitton CC; Meier KE Cells; 2021 Aug; 10(8):. PubMed ID: 34440828 [TBL] [Abstract][Full Text] [Related]
53. Microglial lysophosphatidic acid promotes glioblastoma proliferation and migration via LPA Amaral RF; Geraldo LHM; Einicker-Lamas M; E Spohr TCLS; Mendes F; Lima FRS J Neurochem; 2021 Feb; 156(4):499-512. PubMed ID: 32438456 [TBL] [Abstract][Full Text] [Related]
54. Lysophosphatidic Acid Signaling in Diabetic Nephropathy. Lee JH; Kim D; Oh YS; Jun HS Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31212704 [TBL] [Abstract][Full Text] [Related]
55. Lysophosphatidic acid and its receptors: pharmacology and therapeutic potential in atherosclerosis and vascular disease. Zhou Y; Little PJ; Ta HT; Xu S; Kamato D Pharmacol Ther; 2019 Dec; 204():107404. PubMed ID: 31472182 [TBL] [Abstract][Full Text] [Related]
57. Lipid phosphate phosphatase inhibitors locally amplify lysophosphatidic acid LPA1 receptor signalling in rat brain cryosections without affecting global LPA degradation. Aaltonen N; Lehtonen M; Varonen K; Goterris GA; Laitinen JT BMC Pharmacol; 2012 Jun; 12():7. PubMed ID: 22686545 [TBL] [Abstract][Full Text] [Related]
58. LPA receptor1 antagonists as anticancer agents suppress human lung tumours. Zhao PF; Wu S; Li Y; Bao G; Pei JY; Wang YW; Ma Q; Sun HJ; Damirin A Eur J Pharmacol; 2020 Feb; 868():172886. PubMed ID: 31866407 [TBL] [Abstract][Full Text] [Related]
59. Lysophosphatidic Acid (LPA) Receptor 3-Mediated LPA Signal Transduction Pathways: A Possible Relationship with Early Development of Peri-Implantation Porcine Conceptus. Jeong W; Seo H; Sung Y; Ka H; Song G; Kim J Biol Reprod; 2016 May; 94(5):104. PubMed ID: 27030044 [TBL] [Abstract][Full Text] [Related]
60. Lysophosphatidic acid (LPA) signaling in vertebrate reproduction. Ye X; Chun J Trends Endocrinol Metab; 2010 Jan; 21(1):17-24. PubMed ID: 19836970 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]